Sexuality & Intimacy and Young Cancer Survivors
Online WebinarWe all know that cancer can affect all areas of life and simply changes everything. One topic that is just as much a part of this, but unfortunately is almost never discussed, is sexuality and intimacy. And no, it’s not just cancers of the reproductive organs that change or affect your sex life.
Know the basics: How to advance childhood cancer priorities in the aftermath of the EU elections?
Online WebinarIn the aftermath of the EU elections, the CCI Europe policy team will present the composition of the new elected Parliament and discuss the possible implications for our childhood cancer advocacy priorities. During this webinar, we will talk about the impact of those elections on the nomination of the new Commission leaders, namely
Gold September – Childhood Cancer Awareness Month Event 2024
OnlineCCI-E and SIOPE representing childhood cancer patients, parents, survivors and healthcare professionals, will once again mark the Gold September – Childhood Cancer Awareness Month campaign through the annual flagship policy event on Tuesday, 24 September 2024 at 2 pm CEST that this year will be held online. This year's event aims at increasing awareness
Advance Your Knowledge: What could be the impact of Big Data and AI application in paediatric oncology?
Online WebinarIn this webinar, we will delve into the transformative potential of Big Data and Artificial Intelligence (AI) in paediatric oncology, exploring how these innovative approaches can help cancer research and reshape diagnostics, treatment strategies, and outcomes for children with cancer. Join us to delve into the implications, opportunities, and ethical considerations surrounding the
EU4Health Conference 2024
Palace of the Academies in Brussels Brussels, BelgiumWe are delighted to be a partner of a very special event this year! The EU4Health Integration and Impact Initiative (EU4H3I) aims to address public health challenges such as health inequalities, unequal access to treatments and lack of diversity in clinical trials. Together with our partners, we advocate for interdisciplinary collaboration and the adoption of